Day: March 7, 2026

us corporate news

Alphabet Inc. (GOOG) 8-K Filing March 2026: CEO Compensation, Stock Information, and Senior Notes Details

Minichart

March 7, 2026

Alphabet Inc. Files Form 8-K: Key Shareholder Update A...

Continue Reading 0

us corporate news

iQSTEL Inc. Scales Global Telecom & AI Platform: Revenue Growth, Strategic Acquisitions, and Profit Acceleration (2026)

Minichart

March 7, 2026

iQSTEL Inc. Enters Profit Acceleration Phase: Key Investor H...

Continue Reading 0

us corporate news

Open Lending Corporation (LPRO) Signs Cooperation Agreement with Palogic Value Management – Form 8-K Filing Details and XBRL Data

Minichart

March 7, 2026

Open Lending Corporation Enters Into Key Governance Agreemen...

Continue Reading 0

us corporate news

BXP, Inc. and Boston Properties Limited Partnership Announce $1 Billion Sales Agency Financing Agreement – SEC Filing Details and Participating Agents

Minichart

March 7, 2026

BXP, Inc. - Detailed Investor Update on New Equity Offering ...

Continue Reading 0

us corporate news

T3 Defense Inc. 8-K Filing: Legal Update, Company Details, and NASDAQ Listings (March 2026)

Minichart

March 7, 2026

T3 Defense Inc. Reports Receipt of Legal Summons and Complai...

Continue Reading 0

us corporate news

Reservoir Media Management Executive Employment Agreements March 2026 – CEO, President, CFO Contracts and Compensation Details

Minichart

March 7, 2026

Reservoir Media, Inc. 8-K Report Analysis – Key Investor Hig...

Continue Reading 0

us corporate news

Altimmune, Inc. 2025 Annual Report: Business Overview, Risk Factors, Regulatory Compliance, and Strategic Initiatives

Minichart

March 7, 2026

Altimmune, Inc. Annual Report - Investor Analysis Alti...

Continue Reading 0

us corporate news

PMV Pharmaceuticals 2025 Annual Report: Precision Oncology, p53 Targeted Therapies, Pipeline and Business Overview

Minichart

March 7, 2026

PMV Pharmaceuticals, Inc. 2025 Annual Report - Investor High...

Continue Reading 0

us corporate news

Immuneering Corporation 2025 Annual Report – Deep Cyclic Inhibitor Oncology Pipeline, Clinical Trials, and Bioinformatics Platform Overview

Minichart

March 7, 2026

Immuneering Corp 2025 Annual Report - Investor Highlights ...

Continue Reading 0

us corporate news

Future Vision II Acquisition Corp. 2025 Annual Report: Business Combination with MicroTouch, Risks, and Management Overview

Minichart

March 7, 2026

Future Vision II Acquisition Corp. Releases Annual Report: K...

Continue Reading 0